AAAAAA

   
Results: 1-9 |
Results: 9
Anti-inflammatory effects of chemically modified tetracyclines by the inhibition of nitric oxide and interleukin-12 synthesis in J774 cell line
Authors: D'Agostino, P Ferlazzo, V Milano, S La Rosa, M Di Bella, G Caruso, R Barbera, C Grimaudo, S Tolomeo, M Feo, S Cillari, E
Citation: P. D'Agostino et al., Anti-inflammatory effects of chemically modified tetracyclines by the inhibition of nitric oxide and interleukin-12 synthesis in J774 cell line, INT IMMUNO, 1(9-10), 2001, pp. 1765-1776
Retinoids, apoptosis and cancer
Authors: Simoni, D Tolomeo, M
Citation: D. Simoni et M. Tolomeo, Retinoids, apoptosis and cancer, CUR PHARM D, 7(17), 2001, pp. 1823-1837
Apoptotic effects of thiazolobenzimidazole derivatives on sensitive and multidrug resistant leukaemic cells
Authors: Grimaudo, S Raimondi, MV Capone, F Chimirri, A Poretto, F Monforte, AM Simoni, D Tolomeo, M
Citation: S. Grimaudo et al., Apoptotic effects of thiazolobenzimidazole derivatives on sensitive and multidrug resistant leukaemic cells, EUR J CANC, 37(1), 2001, pp. 122-130
Heterocycle-containing retinoids. Discovery of a novel isoxazole arotinoidpossessing potent apoptotic activity in multidrug and drug-induced apoptosis-resistant cells
Authors: Simoni, D Roberti, M Invidiata, FP Rondanin, R Baruchello, R Malagutti, C Mazzali, A Rossi, M Grimaudo, S Capone, F Dusonchet, L Meli, M Raimondi, MV Landino, M D'Alessandro, N Tolomeo, M Arindam, D Lu, S Benbrook, DM
Citation: D. Simoni et al., Heterocycle-containing retinoids. Discovery of a novel isoxazole arotinoidpossessing potent apoptotic activity in multidrug and drug-induced apoptosis-resistant cells, J MED CHEM, 44(14), 2001, pp. 2308-2318
Effects of chemically modified tetracyclines (CMTs) in sensitive, multidrug resistant and apoptosis resistant leukaemia cell lines
Authors: Tolomeo, M Grimaudo, S Milano, S La Rosa, M Ferlazzo, V Di Bella, G Barbera, C Simoni, D D'Agostino, P Cillari, E
Citation: M. Tolomeo et al., Effects of chemically modified tetracyclines (CMTs) in sensitive, multidrug resistant and apoptosis resistant leukaemia cell lines, BR J PHARM, 133(2), 2001, pp. 306-314
Oral idarubicin in maintenance therapy of acute myeloid leukemia
Authors: Musso, M Porretto, F Crescimanno, A Bondi, F Polizzi, V Scalone, R Tolomeo, M Mariani, G
Citation: M. Musso et al., Oral idarubicin in maintenance therapy of acute myeloid leukemia, HEMAT BLOOD, 40, 2001, pp. 184-190
Programmed cell death (PCD) associated with the stilbene motif of arotinoids: Discovery of novel apoptosis inducer agents possessing activity on multidrug resistant tumor cells
Authors: Simoni, D Roberti, M Invidiata, FP Rondanin, R Baruchello, R Malagutti, C Mazzali, A Rossi, M Grimaudo, S Dusonchet, L Meli, M Raimondi, MV D'Alessandro, N Tolomeo, M
Citation: D. Simoni et al., Programmed cell death (PCD) associated with the stilbene motif of arotinoids: Discovery of novel apoptosis inducer agents possessing activity on multidrug resistant tumor cells, BIOORG MED, 10(23), 2000, pp. 2669-2673
Pig liver esterase (PLE)-mediated resolution of N-substituted 4-benzoyloxy-3-carbomethoxypiperidines: a convenient preparation of 4-hydroxy- and 4-benzoyloxy-3-carbomethoxypiperidines in enantiomerically pure form
Authors: Roberti, M Rondanin, R Ferroni, R Baruchello, R Invidiata, FP Andrisano, V Bertucci, C Bertolasi, V Grimaudo, S Tolomeo, M Simoni, D
Citation: M. Roberti et al., Pig liver esterase (PLE)-mediated resolution of N-substituted 4-benzoyloxy-3-carbomethoxypiperidines: a convenient preparation of 4-hydroxy- and 4-benzoyloxy-3-carbomethoxypiperidines in enantiomerically pure form, TETRAHEDR-A, 11(21), 2000, pp. 4397-4405
Structure-activity relationship studies of novel heteroretinoids: Induction of apoptosis in the HL-60 cell line by a novel isoxazole-containing heteroretinoid
Authors: Simoni, D Invidiata, FP Rondanin, R Grimaudo, S Cannizzo, G Barbusca, E Porretto, F D'Alessandro, N Tolomeo, M
Citation: D. Simoni et al., Structure-activity relationship studies of novel heteroretinoids: Induction of apoptosis in the HL-60 cell line by a novel isoxazole-containing heteroretinoid, J MED CHEM, 42(24), 1999, pp. 4961-4969
Risultati: 1-9 |